The present study suggested that DIRC3, GAP43, and LRP1B are involved in tumor suppressor activity to inhibit thyroid tumorigenesis, and their mutation may reduce the suppression of thyroid cancer risk. Here, LRP1B is linked to thyroid gland carcinoma.